NanoViricides, Inc.NNVCNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank93
5Y CAGR+8.8%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
+8.8%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
4 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 31.30% |
| 2024 | 20.69% |
| 2023 | 9.55% |
| 2022 | -11.44% |
| 2021 | -20.34% |
| 2020 | 20.56% |
| 2019 | -39.13% |
| 2018 | 10.55% |
| 2017 | 6.23% |
| 2016 | 12.57% |